Box 2.
Causes of ADAMTS13 deficiency
Autoimmune antibodies | |
• | Inhibitory IgG antibody of ADAMTS13 causes profound ADAMTS13 deficiency in acquired TTP |
• | The level of the inhibitory antibody is low (< 10 units/mL) in most cases. |
• | The prevalence and significance of non-inhibitory antibodies of ADAMTS13 remain unclear. |
Mutations of the ADAMTS13 gene | |
• | Patients with hereditary TTP are doubly heterozygous or homozygous of mutant alleles. No abnormal phenotypes have been identified in carriers of single mutant alleles. |
• | More than 65 different mutations have been identified, including nonsense, missense, deletion, and splicing. The mutations span the entire spectrum of ADAMTS13 domain structure. |
• | At least 27 polymorphisms have been detected. Certain cis-combinations of polymorphisms may compromise protease secretion/activity. |
• | Genotype-phenotype correlation is unclear because only a few of the mutations have been detected recurrently in more than one pedigree. |
Ig: immunoglobulin; TTP: thrombotic thrombocytopenic purpura.